Kansas Clinical Trials
Browse actively recruiting clinical trials with research sites in Kansas. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Kansas
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesNCT07088068PHASE3SanofiType 1 Diabetes Mellitus
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerWichita, KS
- Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentNCT07708727PHASE2, PHASE3Gilead SciencesHIV-1-infection
- ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)NCT04561518Alnylam PharmaceuticalsTransthyretin-Mediated AmyloidosisKansas City, KS
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast CancerNCT07310420PHASE1TerSera Therapeutics LLCAdvanced Breast Cancer
- A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-Cell
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerNCT07525206PHASE3AbbVieColorectal Cancer
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' DiseaseNCT07661056PHASE3Biohaven Therapeutics Ltd.Graves DiseaseLenexa, KS
- A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney TransplantationNCT07412470PHASE2, PHASE3SanofiKidney Transplant RejectionKansas City, KS
- A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityNCT06830863PHASE1, PHASE2Azitra Inc.EGFR Inhibitor-associated Rash
- ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416PHASE2Alto NeuroscienceBipolar Disorder I or II With a Major Depressive Episode
Popular conditions in Kansas
Frequently asked questions
- How do I find clinical trials in Kansas?
- Corterve aggregates actively recruiting clinical trials with sites in Kansas from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Kansas free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Kansas?
- Kansas research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.